diagnosis of invasive fungal infections
Not Applicable
- Conditions
- Health Condition 1: B376- Candidal endocarditis
- Registration Number
- CTRI/2023/07/055119
- Lead Sponsor
- Max Super Speciality Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Candida Score >3 for Invasive Candidiasis OR
2)Fulfilling Meersseman criteria for Invasive Aspergillosis
Exclusion Criteria
1)Patients < 18 years
2)Patients already on antifungal treatment
3)Unwillingness to participate in study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the efficacy of 1,3-beta-D-Glucan assay for the diagnosis of invasive fungal infections in adults admitted in ICUTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method To calculate mortality and duration of stay in ICU of IFIs in a tertiary care medical ICU.Timepoint: 1 year